COVID-19: Impact in adult patients with premorbid disease: Metabolic diseases (diabetes, obesity)
W. Randerath (Solingen, Germany)
Source: ERS Course 2021 - COVID-19: State of the art
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Related content which might interest you: